Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...
Editor’s Note — March 2026: We’ve updated our story to make sure items are in stock and available, plus we added a new best overall, the Goal Zero 1500 power station, a new model we recently reviewed, ...
Hosted on MSN
UK regulator launches probe into Vistry accountants
March 10 (Reuters) - Britain's regulator for accountants on Tuesday launched an investigation into two individuals over their financial reporting of homebuilder Vistry's South division. The Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results